Since it was found that the risks of hormone therapy outweighed the advantages, scientists have been looking for a safe, all-natural way to alleviate the signs and symptoms of menopause.
Participants are currently becoming recruited for a follow-up medical trial of a treatment recognized as MF101 developed by Bionovo, Inc. In its initial clinical trial, MF101 provided ladies in the research with preliminary proof of reduction from this kind of symptoms as hot flashes and evening sweats, without the dangers related with hormone therapy.
The therapy being examined clinically targets only 1 of the two recognized estrogen receptors-the estrogen receptor beta. Laboratory information has proven that MF101 does not cause the proliferation of breast or uterine most cancers cells the way hormone therapy can, creating the drug a safer alternative to presently accessible hormone therapies.
In 2002, the Women’s Health Initiative (WHI) Estrogen Plus Progestin Trial, with over 16,000 ladies individuals, was stopped early when it was discovered that the regular dose of mixture hormone treatment elevated the danger of breast cancer, stroke, coronary heart attacks, blood clots and dementia.
“Offered the void that exists for a safe and effective treatment for menopausal symptoms, our intention is to discover and create novel drugs such as MF101 that can abate numerous of the symptoms that have historically been handled with hormones,” said Dr. Mary Tagliaferri. Tagliaferri is co-author of “The New Menopause Book: The Experts Help You Make Informed Decisions on HRT, Natural Hormone Therapy, Natural Therapies, Traditional Chinese Medication And More” (Avery, 2006) and Chief Healthcare Officer of Bionovo, which is developing the drug.
The clinical trials will take place below the directorship of renowned researcher Dr. Deborah Grady at four top educational medical centers.
Bionovo expects this Phase two trial to be completed by the second quarter of 2007.
“If this new drug proves to be efficient, we will be providing well being care practitioners with a treatment they can easily suggest to women encountering menopause,” stated Dr. Tagliaferri.
for more resources and information on insulated containers and pharmaceutical packaging and insulated shipping boxes please see our website